AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dagin-M Tablet

Prescription Icon
Prescription Required

Marketer

Bennevolance Life Science

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Dagin-M Tablet

Combiflex-D tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Combiflex-D can be used alone or in conjunction with other antidiabetic therapies. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Taking it with food minimizes gastrointestinal upset. Consistent daily dosing is crucial for maximum effectiveness; discontinue only under your physician's guidance. Effective blood sugar control helps prevent future complications. Continued adherence to your prescribed diet and exercise regimen is vital. Lifestyle choices significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; learn to recognize and treat it. This medication isn't suitable for everyone. Inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or breastfeeding individuals should seek medical advice before use. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Dagin-M Tablet

Managing Type 2 Diabetes

Major Benefits of Dagin-M Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Dagin-M Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

Common Side effects of Dagin-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Dagin-M Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Dagin-M Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Dagin-M Tablet works:

Dagin-M tablets contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Dagin-M tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Dagin-M Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Dagin-M tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential drug transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Dagin-M Tablets. Dosage modifications for Dagin-M Tablets may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Dagin-M Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Dagin-M Tablet :

Should you forget a Dagin-M Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual regimen. Never take a double dose.

Facts to Know About Dagin-M Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Dagin-M Tablet

Dagin-M Tablet administration typically does not induce hypoglycemia (low blood sugar) by itself. However, insufficient caloric intake during treatment may lead to this condition. Nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor are indicative of hypoglycemia. These symptoms are more pronounced if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medications are used. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Nausea and vomiting are potential side effects of Dagin-M Tablet. If vomiting occurs, replenish fluids by sipping small amounts of water or other liquids frequently. Consult your physician if vomiting continues or you experience dehydration symptoms such as infrequent urination and dark, concentrated urine. Always seek medical advice before taking additional medications.
Patients with hypersensitivity to Dagin-M Tablet constituents or inactive ingredients should refrain from its use. This medication is contraindicated in individuals experiencing severe renal dysfunction, hepatic insufficiency, congestive cardiac failure, lactic acidosis, or diabetic ketoacidosis.
Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any remaining medication. Ensure this medicine remains inaccessible to children, pets, and others.
Dagin-M tablets contain metformin and vildagliptin, two medications used to manage diabetes. Metformin, a biguanide, reduces glucose production by the liver, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin secretion from the pancreas. This drug combination is unsuitable for individuals under 18.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of Dagin-M Tablet use. Also termed Metformin-associated lactic acidosis (MALA), this complication is infrequent, prompting avoidance of Dagin-M in individuals with pre-existing kidney impairment, advanced age, or significant alcohol consumption. Presenting symptoms may encompass muscle aches or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Dagin-M Tablet immediately and seek prompt medical attention.
Prolonged Dagin-M Tablet consumption can indeed lead to Vitamin B12 insufficiency. This is due to the medication's impact on the stomach's ability to absorb Vitamin B12. Left unaddressed, this deficiency could result in anemia and neurological complications.
Using Dagin-M tablets as directed by your physician for the recommended period is generally safe. Nevertheless, even with correct dosing, some individuals may encounter typical side effects such as nausea, diarrhea, vomiting, indigestion, headache, stuffy nose, throat irritation, respiratory infection, or low blood sugar (hypoglycemia), particularly when used concurrently with insulin or sulfonylureas. Report any ongoing issues to your doctor during treatment.
Dagin-M Tablet
238
MRP 290
17% off